BRIEF published on 02/19/2025 at 22:10, 1 year 8 months ago Bausch Health Reports Strong Financial Performance in 2024 Adjusted EBITDA Revenue Growth Financial Performance Bausch Health 2024 Results
PRESS RELEASE published on 02/19/2025 at 22:05, 1 year 8 months ago Bausch Health Announces Fourth Quarter and Full-Year 2024 Results Bausch Health Companies Inc. announces strong Q4 and full-year 2024 financial results, achieving revenue growth in all segments and exceeding adjusted EBITDA guidance Financial Results Adjusted EBITDA Revenue Growth Bausch Health Q4 2024
BRIEF published on 02/14/2025 at 14:05, 1 year 8 months ago Bausch Health participera à la conférence financière de JP Morgan Webcast Soins De Santé Bausch Santé Pharmaceutique Conférence Sur Les Finances
BRIEF published on 02/14/2025 at 14:05, 1 year 8 months ago Bausch Health to Attend J.P. Morgan Finance Conference Healthcare Pharmaceutical Webcast Bausch Health Finance Conference
PRESS RELEASE published on 02/14/2025 at 14:00, 1 year 8 months ago Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Bausch Health Companies Inc. to participate in 2025 J.P. Morgan Global Leveraged Finance Conference on February 24. Webcast available on Investor Relations section of Bausch Health's website Investor Relations Webcast Conference Bausch Health J.P. Morgan
BRIEF published on 02/10/2025 at 14:05, 1 year 8 months ago Bausch Health Launches 2025 Salix GI Health Scholars Program Salix Pharmaceuticals Bausch Health Higher Education GI Diseases Scholarship Program
BRIEF published on 02/10/2025 at 14:05, 1 year 8 months ago Bausch Health lance le programme de bourses d'études Salix GI Health 2025 Bausch Santé Enseignement Supérieur Programme De Bourses D'études Produits Pharmaceutiques Salix Maladies Gastro-intestinales
PRESS RELEASE published on 02/10/2025 at 14:00, 1 year 8 months ago Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Bausch Health and Salix Pharmaceuticals launch 2025 Salix Gastrointestinal Health Scholars Program, offering scholarships for students living with GI diseases. Application deadline on May 5, 2025 Salix Pharmaceuticals Bausch Health Scholarships GI Diseases 2025
BRIEF published on 02/06/2025 at 13:10, 1 year 8 months ago Bausch Health Decides Against Sale of Bausch + Lomb Financial Performance Bausch Health Liability Management Bausch + Lomb Sale Decision
BRIEF published on 02/06/2025 at 13:10, 1 year 8 months ago Bausch Health décide de ne pas vendre Bausch + Lomb Performance Financière Bausch Santé Bausch + Lomb Décision De Vente Gestion De La Responsabilité
Published on 11/06/2026 at 05:15, 1 hour 30 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 5 hours 52 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 6 hours ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 6 hours 50 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/06/2026 at 04:55, 1 hour 50 minutes ago Segway Powersports Strengthens European Dealer Partnerships at EICMA 2026
Published on 11/06/2026 at 04:15, 2 hours 30 minutes ago Geely’s i-HEV Intelligent Hybrid Technology Offers a New Direction Vision for Gasoline-Powered Vehicles
Published on 11/06/2026 at 04:15, 2 hours 30 minutes ago La technologie hybride intelligente i-HEV de Geely ouvre de nouvelles perspectives pour les voitures à essence
Published on 11/06/2026 at 03:55, 2 hours 50 minutes ago Coway Announces Financial Results for Q3 FY2026
Published on 11/05/2026 at 18:21, 12 hours 23 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 12 hours 23 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
